# Use of Naltrexone in a Clinical Setting

> **NCT00000445** · PHASE4 · COMPLETED · sponsor: **National Institute on Alcohol Abuse and Alcoholism (NIAAA)** · enrollment: 300 (—)

## Conditions studied

- Alcoholism

## Interventions

- **DRUG:** naltrexone (Revia)

## Key facts

- **NCT ID:** NCT00000445
- **Lead sponsor:** National Institute on Alcohol Abuse and Alcoholism (NIAAA)
- **Sponsor class:** NIH
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** 2002-09
- **Target enrollment:** 300 (—)
- **Last updated:** 2005-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00000445

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00000445, "Use of Naltrexone in a Clinical Setting". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00000445. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*